| « Previous month | Next month » |
Newly formed independent business, Sterilin Ltd., is aiming to increase the quality of laboratory analyses with its range of single-use labware.
High throughput (HT) screening expert IonGate has joined forces with liquid handling quality assurance leader Artel to support its drug discovery research technology in the US.
Sigma-Aldrich has introduced a new high-throughput (HT) plasmid DNA purification kit for transfection applications in pharmaceutical and biotechnology research.
US researchers have developed a more sensitive method of detecting whether athletes have taken drugs to artificially boost testosterone which increases physical performance.
WuXi PharmaTech has formed a joint venture with its US-based peer Covance, in a deal which will create a powerhouse in drug development services.
Dutch assay experts Qiagen are aiming to remove the bottlenecks hindering important research into the epigenetics of cancer and hereditary diseases with the expansion of its EpiTect product line.
Cordium Links has partnered with an unnamed Chinese firm to bring electrocardiogram (ECG) laboratory services to companies performing cardiac safety evaluation as part of clinical research in China - claiming to be the first firm to introduce services of this kind into the country.
Invitrogen plans to cement its place as one of the world's largest suppliers of analysis tools and reagents for the life science and pharmaceutical industries by acquiring Applied Biosystems (ABI).
Beckman Coulter and Orchid Cellmark have filed a lawsuit against Sequenom in another patent infringement case that alleges Sequenom is guilty of violating patents belonging to Orchid and licensed to Beckman.
GE Healthcare has announced its intention to invest $20m in radical new technology, which will allow laboratory research results to be transmitted and shared amongst doctors worldwide setting to define a new age in patient care.
In the latest biotechnology courtroom battle, Oxford Gene Technology (OGT) reported that it has filed suit against BioArray Solutions for deliberately infringing three of its patents that relates to technology capable of detailed cell analysis using a silicon chip.
AstraZeneca's travels down the outsourcing route have continued this week, with an extension to its contract with China's WuXi Pharmatech.
A company based in the US and Germany has set up what it describes as a 'Facebook for scientists', in a move that brings the phenomenon of social networking firmly into the workplace.
Sartorius Stedim Biotech has teamed up with Wuxi AppTec to help companies remove some of the strain of carrying out viral clearance testing, which for large biopharmaceutical companies can carry a price tag of up to $1m a year.
Personalised medicine took a giant leap forward this week as the regulation of an oestrogen receptor was reported in a unique study that has implications in the diagnosis and subsequent treatment for breast cancer.
Life Science equipment specialists Thermo Fisher Scientific has launched its latest liquid chromatography-mass spectrometry (LC-MS) system, which builds on existing mass analyser technology to produce a instrument for scientists in analytical laboratories.
A new European initiative that brings together biological material, such as DNA, tissue, cells or other human samples within a central 'biobank' infrastructure is set to be given the go-ahead creating a unique collection that will aid drug discovery, personalised medicines and future therapies.
The American Society for Mass Spectrometry meeting (ASMS) was the scene of a lot of activity from Agilent this week as the lab instrument specialist unleashed new mass spectrometer products at the show.
Agilent Technologies has licensed BIA Separations' bio-monolithic technology and intends to use it in the commercialisation of analytical high performance liquid chromatography (HPLC) bio-monolith columns.
MDS Pharma Services has expanded its portfolio of bioanalytical testing services with the addition of electrochemiluminescent assay (ECLA) capability, used to test biological samples from clinical research participants.
China's Wuxi PharmaTech saw revenues race away across its divisions in the first quarter of 2008, benefitting from the continued shift towards outsourcing of manufacturing and laboratory functions by the pharmaceutical industry.
| « Previous month | Next month » |